GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced Obesity Mice

GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced Obesity Mice

Takashi Nakamura, Hitomi Tanimoto, Masayuki Okamoto, Mitsuaki Takeuchi, Yoshiharu Tsubamoto, Hitoshi Noda Biological Research Group Drug Discovery Laboratories, Sanwa Kagaku Kenkyusho, Mie, JapanCorrespondence: Takashi NakamuraSanwa Kagaku Kenkyusho, Biological Research Group Drug Discovery Laborato...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Nakamura T, Tanimoto H, Okamoto M, Takeuchi M, Tsubamoto Y, Noda H
Format: article
Langue:EN
Publié: Dove Medical Press 2021
Sujets:
gip，gip receptor antagonist
anti-obesity
lipase activity
lipid metabolism
Specialties of internal medicine
RC581-951
Accès en ligne:https://doaj.org/article/b29c9f85c08944e3bddec566adf6b750
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/b29c9f85c08944e3bddec566adf6b750

Documents similaires